RxDoctor Payments Data

Jenifer Gillis, PA

Physician Assistant · Tacoma, WANPI 1215078050

Payments from drug & device makers

$872in general payments, 2019–2025

Across 32 payments — averaging $27.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$211
  • Biohaven Pharmaceuticals, Inc.$202
  • AbbVie$175
  • Pfizer$69
  • Lilly USA, LLC$59
  • Amgen$52
  • plus $103 from 3 others

What the payments were for

  • Food & beverage$86499%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$872 in reported general payments places this provider in the 80th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$6,631
Medicare patients
51
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$16,445
EliquisApixaban17$13,665
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,731
Insulin Degludec Pen (U-100)Insulin Degludec14$2,606
Atorvastatin Calcium93$1,085
Rosuvastatin Calcium42$908
Amlodipine Besylate70$696
Duloxetine Hcl37$674
Lisinopril60$628
Metoprolol Succinate46$598
Celecoxib20$449
SynthroidLevothyroxine Sodium13$431
Albuterol Sulfate HfaAlbuterol Sulfate12$408
Pantoprazole Sodium37$387
Baclofen19$382

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$13,66517 claims
Boehringer IngelheimStiolto Respimat$50$5,73112 claims
AbbVieSynthroid$175$43113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →